Ignite Creation Date:
2024-05-06 @ 11:22 AM
Last Modification Date:
2024-10-26 @ 12:44 PM
Study NCT ID:
NCT03504852
Status:
COMPLETED
Last Update Posted:
2021-10-11
First Post:
2018-03-29
Brief Title:
Efficacy and Safety of 2 Secukinumab Regimens in 90kg or More Weight Group With ModerateSevere Chronic Plaque Psoriasis
Sponsor:
Novartis Pharmaceuticals
Organization:
Novartis
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-06-25
Start Date Type:
ACTUAL
Primary Completion Date:
2019-09-13
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-07-15
Completion Date Type:
ACTUAL
First Submit Date:
2018-03-29
First Submit QC Date:
April 12 2018
Study First Post Date:
2018-04-20
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2021-06-07
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
2020-07-16
Disp First Submit QC Date:
July 16 2020
Disp First Post Date:
2020-07-20
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2021-10-07
Last Update Post Date:
2021-10-11
Last Update Post Date Type:
ACTUAL